Apcegen Technologies Overview

  • Founded
  • 2010
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $1.5K
Latest Deal Amount
  • Investors
  • 2

Apcegen Technologies General Information


Provider of digital biopharma platform intended to develop, manufacture and commercialize affordable bio pharmaceuticals for the treatment of inflammation. The company's platform focuses on the development of a battery of recombinant therapeutics aimed to combat diseases like rheumatoid arthritis and cancers, enabling patients with affordable biotechnology based healthcare services through GMP compliant fast track development of bioprocesses for the development of biotherapeutic products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Primary Office
  • B901 Daadys Elixir
  • Near APMC fruit Market Electronic City - II
  • Bengaluru, Karnataka 560100
  • India
+91 090058 00000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Apcegen Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 10-Sep-2016 $1.5K Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Apcegen Technologies’s complete valuation and funding history, request access »

Apcegen Technologies Executive Team (3)

Name Title Board Seat Contact Info
Ashutosh Vyas Co-Founder, Chief Executive Officer & Head of Biopharmaceuticals
Rajiv Mahajan Chief Technology Officer
Amita Vyas Co-Founder, Chief Managing Director & CMO
To view Apcegen Technologies’s complete executive team members history, request access »

Apcegen Technologies Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ISBA Government 000 0000 000000 0
SIDBI Innovation & Incubation Center Accelerator/Incubator Minority 000 0000 000000 0
To view Apcegen Technologies’s complete investors history, request access »